2016-08-19 |
1 |
|
United States Patent Nos. 7,439,241 (“the
’241 patent”); 8,426,410 (“the ’410 patent”); 8,859,551 (“… of the ’241 patent, the ’410 patent, the ’551 patent, the
’102 patent, the ’247 patent, and the ’249…1), the ’241 patent, the ’410 patent, the ’551
patent, the ’102 patent, the ’247 patent, and the ’249… of the
’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249…
of the ’241 patent, the ’410 patent, the ’551 patent, the ’102 patent, the ’247 patent, and the ’249 |
External link to document |
2016-08-19 |
3 |
|
Notice: July 7, 2016. Date of Expiration of Patent: 7,439,241 - August 25, 2025 10,102 - May 24, 2025 8,…
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2016
6 December 2016
1:16-cv-00732
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-08-19 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,439,241 B2; 8,410,102 B2; 8,426,410…2016
6 December 2016
1:16-cv-00732
830 Patent
None
District Court, D. Delaware
|
External link to document |